Expression of microRNAs and its relationship with cardiac remodeling in hypertensive patients

• Grant number: 17/23563-1
• Support Opportunities: Regular Research Grants
• Start date: March 01, 2018
• End date: February 29, 2020
• Field of knowledge: Biological Sciences - Biochemistry - Molecular Biology
• Principal Investigator: Roberto Schreiber
• Grantee: Roberto Schreiber
• Host Institution: Faculdade de Ciências Médicas (FCM). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil
• Associated researchers: José Roberto Matos Souza ; Layde Rosane Paim ; Wilson Nadruz Junior

Abstract

Hypertension is recognized worldwide as a public health problem, because of its high prevalence and incidence in the population. In addition, it is the primary risk factor for the development of other cardiovascular diseases, and may promote target organ damage, in particular left ventricular hypertrophy. MicroRNAs (miRNAs) are a group of small molecules (22 nucleotides) of non-coding RNA, evolutionarily conserved, which act by binding to complementary sites on target mRNAs to induce cleavage or repression of protein translation. Several studies suggest that aberrant expression of miRNAs may be involved in the development of cardiac hypertrophy, however little is known about the role of miRNA expression in the development of hypertensive cardiomyopathy. Therefore, the study of miRNAs can lead to the discovery of potential biomarkers for target organ damage in hypertensive patients. Preliminary results from our group demonstrated differential expression of at least 10 miRNAs between hypertensive patients with left ventricular hypertrophy (LVH) and non-LVH. The present study aims to expand the investigation of serum miRNA expression and to correlate this data with left ventricular mass (LVM) and geometry in hypertensive patients. In addition, we intend to evaluate the role of these miRNAs in cardiac myocyte hypertrophy in vitro. (AU)

Scientific publications

(5)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

BUENO, LARISSA C. M.; PAIM, LAYDE R.; MININ, EDUARDA O. Z.; DA SILVA, LUIS MIGUEL; MENDES, PAULO R.; KIYOTA, TATIANA A.; SCHREIBER, ANGELICA Z.; BOMBASSARO, BRUNA; MANSOUR, ELI; MORETTI, MARIA LUIZA; et al. Increased Serum Mir-150-3p Expression Is Associated with Radiological Lung Injury Improvement in Patients with COVID-19. Viruses-Basel, v. 14, n. 7, p. 11-pg., 2022-07-01. (17/23563-1, 13/07607-8)

MININ, EDUARDA O. Z.; PAIM, LAYDE R.; LOPES, ELISANGELA C. P.; BUENO, LARISSA C. M.; CARVALHO-ROMANO, LUIS F. R. S.; MARQUES, EDMILSON R.; VEGIAN, CAMILA F. L.; PIO-MAGALHAES, JOSE A.; COELHO-FILHO, OTAVIO R.; SPOSITO, ANDREI C.; et al. Association of Circulating miR-145-5p and miR-let7c and Atherosclerotic Plaques in Hypertensive Patients. BIOMOLECULES, v. 11, n. 12, DEC 2021. (17/23563-1)

LOPES, ELISANGELA C. P.; PAIM, LAYDE R.; MATOS-SOUZA, JOSE R.; CALEGARI, DECIO R.; GORLA, JOSE I.; CLIQUET, JR., ALBERTO; LIMA, CARMEN S. P.; MCDONALD, JOHN F.; NADRUZ, JR., WILSON; SCHREIBER, ROBERTO. Bioinformatics analysis of circulating miRNAs related to cancer following spinal cord injury. BIOSCIENCE REPORTS, v. 39, n. 9, SEP 20 2019. (17/23563-1)

LOPES, ELISANGELA C. P.; PAIM, LAYDE R.; CARVALHO-ROMANO, LUIS F. R. S.; MARQUES, EDMILSON R.; MININ, EDUARDA O. Z.; VEGIAN, CAMILA F. L.; PIO-MAGALHAES, JOSE A.; VELLOSO, LICIO A.; COELHO-FILHO, OTAVIO R.; SPOSITO, ANDREI C.; et al. Relationship Between Circulating MicroRNAs and Left Ventricular Hypertrophy in Hypertensive Patients. FRONTIERS IN CARDIOVASCULAR MEDICINE, v. 9, p. 9-pg., 2022-04-13. (17/23563-1, 13/07607-8)

LOPES, ELISANGELA C. P.; PAIM, LAYDE R.; MATOS-SOUZA, JOSE R.; CALEGARI, DECIO R.; GORLA, JOSE I.; CLIQUET, ALBERTO, JR.; LIMA, CARMEN S. P.; MCDONALD, JOHN F.; NADRUZ, WILSON, JR.; SCHREIBER, ROBERTO. Bioinformatics analysis of circulating miRNAs related to cancer following spinal cord injury. BIOSCIENCE REPORTS, v. 39, p. 7-pg., 2019-09-20. (17/23563-1)